Major or Mild Neurocognitive Disorder Due to Vascular Disease

Clinical picture

• Processing speed, complex attention, and executive function fail before memory, so patients appear slowed and disorganized rather than forgetful.
• Decline is classically stepwise after clinical strokes, but small vessel disease produces a gradual course that mimics Alzheimer's on history alone.
• Focal neurological findings are common: gait disturbance, urinary urgency, brisk reflexes, pseudobulbar affect, and early falls.
• Memory failure is retrieval-based and improves with cueing and recognition, unlike the rapid forgetting and failed encoding of Alzheimer's disease.
• Apathy, emotional lability, and post-stroke depression are prominent and often burden families more than the cognitive deficits themselves.
• Insight is relatively preserved early, so patients report their own decline more often than families do at first presentation.

Criteria snapshot

• Criteria for major or mild neurocognitive disorder are met, with decline documented by informant report plus objective cognitive testing.
• Clinical features suggest a vascular etiology: onset tied to a cerebrovascular event, or prominent decline in complex attention and frontal executive function.
• Evidence of cerebrovascular disease from history, physical examination, or neuroimaging is sufficient to account for the observed deficits.
• Probable vascular etiology requires neuroimaging support, a clear temporal link to stroke, or genetic evidence; otherwise the etiology is called possible.
• Symptoms are not better explained by another brain disease or systemic disorder; specify major or mild, with or without behavioral disturbance.

Neurobiology

• Mechanisms span large-vessel infarcts, strategic single infarcts in thalamus or angular gyrus, lacunes, hemorrhage, and diffuse white matter ischemia.
• Subcortical small vessel disease disconnects frontal-subcortical circuits, which explains the executive and processing-speed signature of the syndrome.
• MRI shows white matter hyperintensities, lacunes, microbleeds, and enlarged perivascular spaces, graded with the Fazekas scale and STRIVE criteria.
• Hypertension, diabetes, atrial fibrillation, smoking, dyslipidemia, and obstructive sleep apnea are the dominant modifiable risk factors.
• CADASIL, caused by NOTCH3 mutations, produces early-onset subcortical disease with migraine with aura and merits testing before age 60.
• Mixed Alzheimer's and vascular pathology is the most common substrate found at autopsy in dementia beginning after age 80.

Psychology

• Frontal-subcortical disconnection produces apathy that families read as laziness or depression, a distinction that changes the entire management plan.
• Insight preserved early in the course drives real demoralization, and post-stroke depression affects roughly one-third of stroke survivors.
• Pseudobulbar affect, with laughing or crying detached from felt emotion, distresses families, is commonly misread as lability, and is treatable.
• Slowed processing means patients answer correctly when given time, so rushed interviews and hurried caregiving manufacture apparent impairment.
• Behavioral activation and structured routine counter apathy far more reliably than encouragement or insight-oriented approaches.

Differential & comorbidity

• Alzheimer's disease shows insidious amnestic onset with little benefit from cueing, while vascular disease shows executive slowing with focal signs.
• Lewy body disease brings fluctuating attention, visual hallucinations, parkinsonism, and REM sleep behavior disorder, with gait overlap adding confusion.
• Normal pressure hydrocephalus presents with gait apraxia, urinary incontinence, and cognitive slowing, and is potentially reversible with shunting.
• Depression, delirium, obstructive sleep apnea, and medication effects mimic or amplify vascular cognitive impairment and should be treated first.
• Stroke, cardiac disease, diabetes, and depression coexist as the rule, so care is inherently multidisciplinary and medically driven.

Pharmacologic treatment

• Secondary stroke prevention is the core treatment: antihypertensives, statins, antiplatelet therapy, and anticoagulation for atrial fibrillation.
• Target blood pressure below 130/80 mm Hg where tolerated, since intensive control reduced incident cognitive impairment in randomized trials.
• Cholinesterase inhibitors and memantine offer minimal benefit in pure vascular disease, though they are reasonable when Alzheimer's pathology coexists.
• Treat post-stroke depression with an SSRI such as sertraline or escitalopram, weighing bleeding risk alongside antithrombotic therapy.
• Dextromethorphan-quinidine is approved for pseudobulbar affect and rapidly reduces involuntary episodes of crying and laughing.

Psychotherapy

• Cognitive rehabilitation aimed at attention, planning, and error monitoring fits the executive profile far better than memory drills.
• Behavioral activation and problem-solving therapy treat post-stroke depression and apathy, with good evidence in rehabilitation settings.
• Caregiver psychoeducation reframes apathy as a symptom of brain injury rather than a choice, which reduces conflict and caregiver strain.
• CBT adapted for slowed processing, using shorter sessions and written summaries, treats comorbid anxiety and depression effectively.
• Goal-oriented rehabilitation with occupational and speech therapy after stroke yields real functional gains over the following months.

Adjunct options

• Cardiovascular risk management is dementia treatment here: blood pressure, glucose, lipids, smoking cessation, and atrial fibrillation control.
• Aerobic exercise improves executive function and gait, and structured physical therapy reduces the fall risk that drives hospitalization.
• Treat obstructive sleep apnea with CPAP, since untreated apnea worsens vascular risk and cognitive performance simultaneously.
• Assess with the MoCA, which detects the executive deficits the MMSE misses, adding clock draw and trail making for frontal function.
• Address driving safety, falls, home modification, and advance care planning early, given the stepwise and unpredictable trajectory.

Clinical pearls

• Executive slowing with focal neurological signs, not amnesia, is the vascular signature.
• Cueing rescues recall in vascular disease; in Alzheimer's disease it does not.
• Treating blood pressure is the most effective drug therapy available here.